publication date: Mar. 23, 2018
Conversation with the Cancer Letter
NYU’s Caplan: Right to Try laws are meaningless, empty hot air, unethical, and utterly ineffective
Arthur L. Caplan
Drs. William F. and Virginia Connolly Mitty Professor,
Founding director of the Division of Medical Ethics,
New York University School of Medicine
The right-to-try bills passed by Congress would remove FDA’s expanded access mandate and leave patients at greater risk, said Arthur Caplan, the Drs. William F. and Virginia Connolly Mitty Professor and founding director of the Division of Medical Ethics at the New York University School of Medicine.
“Not only am I saying [right-to-try] is meaningless and empty hot air, we at NYU have a counter effort that we’ve done, to try and incentivize and work with companies,” Caplan said. “The only way to understand this FDA animus that Goldwater has is that they’re on an anti-regulatory kick, because the other number that we established pretty clearly is that the FDA approved somewhere between 99.4 and 99.6 percent of company-granted requests.
“The FDA is happy to sign off, as long as the company is willing to give. [The agency is] not an obstacle or hindrance to patients.”
Caplan spoke with Matthew Ong, a reporter with The Cancer Letter.
The latest right-to-try bill has cleared the House. What’s your take on … Continue reading NYU’s Caplan: Right to Try laws are meaningless, empty hot air, unethical, and utterly ineffective
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.